411 related articles for article (PubMed ID: 10861783)
1. Absence of P0 leads to the dysregulation of myelin gene expression and myelin morphogenesis.
Xu W; Manichella D; Jiang H; Vallat JM; Lilien J; Baron P; Scarlato G; Kamholz J; Shy ME
J Neurosci Res; 2000 Jun; 60(6):714-24. PubMed ID: 10861783
[TBL] [Abstract][Full Text] [Related]
2. Protein zero is necessary for E-cadherin-mediated adherens junction formation in Schwann cells.
Menichella DM; Arroyo EJ; Awatramani R; Xu T; Baron P; Vallat JM; Balsamo J; Lilien J; Scarlato G; Kamholz J; Scherer SS; Shy ME
Mol Cell Neurosci; 2001 Dec; 18(6):606-18. PubMed ID: 11749037
[TBL] [Abstract][Full Text] [Related]
3. Proteolipid protein modulates preservation of peripheral axons and premature death when myelin protein zero is lacking.
Patzig J; Kusch K; Fledrich R; Eichel MA; Lüders KA; Möbius W; Sereda MW; Nave KA; Martini R; Werner HB
Glia; 2016 Jan; 64(1):155-74. PubMed ID: 26393339
[TBL] [Abstract][Full Text] [Related]
4. Proteolipid protein cannot replace P0 protein as the major structural protein of peripheral nervous system myelin.
Yin X; Kiryu-Seo S; Kidd GJ; Feltri ML; Wrabetz L; Trapp BD
Glia; 2015 Jan; 63(1):66-77. PubMed ID: 25066805
[TBL] [Abstract][Full Text] [Related]
5. Subtle roles of neural cell adhesion molecule and myelin-associated glycoprotein during Schwann cell spiralling in P0-deficient mice.
Carenini S; Montag D; Schachner M; Martini R
Glia; 1999 Sep; 27(3):203-12. PubMed ID: 10457367
[TBL] [Abstract][Full Text] [Related]
6. Myelin basic protein gene dosage effects in the PNS.
Smith-Slatas C; Barbarese E
Mol Cell Neurosci; 2000 Apr; 15(4):343-54. PubMed ID: 10845771
[TBL] [Abstract][Full Text] [Related]
7. Localization and functional roles of PMP22 in peripheral nerves of P0-deficient mice.
Carenini S; Neuberg D; Schachner M; Suter U; Martini R
Glia; 1999 Dec; 28(3):256-64. PubMed ID: 10559784
[TBL] [Abstract][Full Text] [Related]
8. Levels of proteolipid protein mRNAs in peripheral nerve are not under stringent axonal control.
Gupta SK; Pringle J; Poduslo JF; Mezei C
J Neurochem; 1991 May; 56(5):1754-62. PubMed ID: 1707441
[TBL] [Abstract][Full Text] [Related]
9. Regulation of myelin-specific gene expression. Relevance to CMT1.
Kamholz J; Awatramani R; Menichella D; Jiang H; Xu W; Shy M
Ann N Y Acad Sci; 1999 Sep; 883():91-108. PubMed ID: 10586235
[TBL] [Abstract][Full Text] [Related]
10. Coexpression of PMP22 gene with MBP and P0 during de novo myelination and nerve repair.
Kuhn G; Lie A; Wilms S; Müller HW
Glia; 1993 Aug; 8(4):256-64. PubMed ID: 7691737
[TBL] [Abstract][Full Text] [Related]
11. The alpha-chemokine CXCL14 is up-regulated in the sciatic nerve of a mouse model of Charcot-Marie-Tooth disease type 1A and alters myelin gene expression in cultured Schwann cells.
Barbaria EM; Kohl B; Buhren BA; Hasenpusch-Theil K; Kruse F; Küry P; Martini R; Müller HW
Neurobiol Dis; 2009 Mar; 33(3):448-58. PubMed ID: 19111616
[TBL] [Abstract][Full Text] [Related]
12. The absence of myelin P0 protein produces a novel molecular phenotype in Schwann cells.
Menichella DM; Xu W; Jiang H; Sohi J; Vallat JM; Baron P; Kamholz J; Shy M
Ann N Y Acad Sci; 1999 Sep; 883():281-93. PubMed ID: 10586253
[TBL] [Abstract][Full Text] [Related]
13. P0 protein is required for and can induce formation of schmidt-lantermann incisures in myelin internodes.
Yin X; Kidd GJ; Nave KA; Trapp BD
J Neurosci; 2008 Jul; 28(28):7068-73. PubMed ID: 18614675
[TBL] [Abstract][Full Text] [Related]
14. Molecular bases of myelin formation as revealed by investigations on mice deficient in glial cell surface molecules.
Martini R; Schachner M
Glia; 1997 Apr; 19(4):298-310. PubMed ID: 9097074
[TBL] [Abstract][Full Text] [Related]
15. Evolution of a neuroprotective function of central nervous system myelin.
Yin X; Baek RC; Kirschner DA; Peterson A; Fujii Y; Nave KA; Macklin WB; Trapp BD
J Cell Biol; 2006 Jan; 172(3):469-78. PubMed ID: 16449196
[TBL] [Abstract][Full Text] [Related]
16. Increased P0 glycoprotein gene expression in primary and transfected rat Schwann cells after treatment with axolemma-enriched fraction.
Knight RM; Fossom LH; Neuberger TJ; Attema BL; Tennekoon G; Bharucha V; DeVries GH
J Neurosci Res; 1993 May; 35(1):38-45. PubMed ID: 7685396
[TBL] [Abstract][Full Text] [Related]
17. Phenotypic differences between peripheral myelin protein-22 (PMP22) and myelin protein zero (P0) mutations associated with Charcot-Marie-Tooth-related diseases.
Shames I; Fraser A; Colby J; Orfali W; Snipes GJ
J Neuropathol Exp Neurol; 2003 Jul; 62(7):751-64. PubMed ID: 12901701
[TBL] [Abstract][Full Text] [Related]
18. Sex-dimorphic effects of progesterone and its reduced metabolites on gene expression of myelin proteins by rat Schwann cells.
Magnaghi V; Veiga S; Ballabio M; Gonzalez LC; Garcia-Segura LM; Melcangi RC
J Peripher Nerv Syst; 2006 Jun; 11(2):111-8. PubMed ID: 16787508
[TBL] [Abstract][Full Text] [Related]
19. Modification of Schwann cell phenotype with Plp transgenes: evidence that the PLP and DM20 isoproteins are targeted to different cellular domains.
Anderson TJ; Montague P; Nadon N; Nave KA; Griffiths IR
J Neurosci Res; 1997 Oct; 50(1):13-22. PubMed ID: 9379489
[TBL] [Abstract][Full Text] [Related]
20. Temporal expression pattern of peripheral myelin protein 22 during in vivo and in vitro myelination.
Notterpek L; Snipes GJ; Shooter EM
Glia; 1999 Feb; 25(4):358-69. PubMed ID: 10028918
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
